Skip to main content
Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
16.99
-0.26 (-1.51%)
At close: Feb 27, 2026, 4:00 PM EST
16.80
-0.19 (-1.12%)
After-hours: Feb 27, 2026, 6:49 PM EST

Eton Pharmaceuticals Revenue

Eton Pharmaceuticals had revenue of $22.46M in the quarter ending September 30, 2025, with 117.54% growth. This brings the company's revenue in the last twelve months to $70.32M, up 102.77% year-over-year. In the year 2024, Eton Pharmaceuticals had annual revenue of $39.01M with 23.29% growth.

Revenue (ttm)
$70.32M
Revenue Growth
+102.77%
P/S Ratio
6.48
Revenue / Employee
$2,268,258
Employees
31
Market Cap
455.63M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202439.01M7.37M23.29%
Dec 31, 202331.64M10.39M48.90%
Dec 31, 202221.25M-581.00K-2.66%
Dec 31, 202121.83M21.79M55,879.49%
Dec 31, 202039.00K-920.00K-95.93%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 788.90M
Organogenesis Holdings 465.22M
Esperion Therapeutics 303.80M
Ironwood Pharmaceuticals 296.15M
Evolus 285.82M
Akebia Therapeutics 225.07M
Canopy Growth 203.04M
Kamada 174.79M
Revenue Rankings

ETON News

More News